Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial.

ABSTRACT:

SUBMITTER: Wei AH 

PROVIDER: S-EPMC10542842 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature